Amy Wagers

Amy Wagers is a professor of stem cell and regenerative biology at Harvard University and Harvard Medical School, an investigator in islet cell and regenerative biology at the Joslin Diabetes Center, and principal faculty of the Harvard Stem Cell Institute.^[2] She started her education at Johns Hopkins University and received her B.A. in Biological Sciences and her Ph.D. in Immunology and Microbial Pathogenesis from Northwestern University in 1999, and completed her postdoctoral fellowship in the laboratory of Dr. Irving Weissman at Stanford University School of Medicine.^[3] Wagers researches intrinsic and extrinsic regulators of stem cell function and how stem cells impact tissue regeneration and aging. She has demonstrated that transplantation of satellite cells into injured, diseased, or aged muscle can lead to cell engraftment, in some cases restoring muscle function. She has also identified novel regulators (such as EGR1) of stem cell trafficking and stem cell number in bone marrow and during immune responses, and identified blood-borne proteins, such as GDF11, that in mice can reverse some of the pathological changes that occur in aging tissues. ^[3][4] She enjoys trapeze lessons and skydiving^[2] Around the year 2010, two publications from a postdoctoral researcher in the Wagers lab were retracted. The researcher was dismissed from the lab.^[5][6]

Awards

• Burroughs Wellcome Fund Career Award in the Biomedical Sciences^[3]
• Smith Family New Investigator Award^[3]
• Forst Family Professor of Stem Cell and Regenerative Biology^[4]
• The New York Stem Cell Foundation's Robertson Stem Cell Prize^[7]

References